277 related articles for article (PubMed ID: 23883651)
21. Autonomic regulation therapy for the improvement of left ventricular function and heart failure symptoms: the ANTHEM-HF study.
Dicarlo L; Libbus I; Amurthur B; Kenknight BH; Anand IS
J Card Fail; 2013 Sep; 19(9):655-60. PubMed ID: 24054343
[TBL] [Abstract][Full Text] [Related]
22. Vagus nerve stimulation reverses ventricular electrophysiological changes induced by hypersympathetic nerve activity.
Huang J; Qian J; Yao W; Wang N; Zhang Z; Cao C; Song B; Zhang Z
Exp Physiol; 2015 Mar; 100(3):239-48. PubMed ID: 25720663
[TBL] [Abstract][Full Text] [Related]
23. Implantable vagus nerve stimulation system performance is not affected by internal or external defibrillation shocks.
Libbus I; Stubbs SR; Mazar ST; Mindrebo S; KenKnight BH; DiCarlo LA
J Interv Card Electrophysiol; 2022 Apr; 63(3):555-560. PubMed ID: 34467496
[TBL] [Abstract][Full Text] [Related]
24. Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure.
Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Goldstein S; Sabbah HN
J Am Coll Cardiol; 2000 Jan; 35(1):222-9. PubMed ID: 10636284
[TBL] [Abstract][Full Text] [Related]
25. Vagus nerve stimulation: A new approach to reduce heart failure.
Klein HU; Ferrari GM
Cardiol J; 2010; 17(6):638-44. PubMed ID: 21154273
[TBL] [Abstract][Full Text] [Related]
26. Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs.
Rastogi S; Guerrero M; Wang M; Ilsar I; Sabbah MS; Gupta RC; Sabbah HN
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1501-9. PubMed ID: 21217070
[TBL] [Abstract][Full Text] [Related]
27. Darbepoetin-alpha prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure.
Rastogi S; Imai M; Sharov VG; Mishra S; Sabbah HN
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2475-82. PubMed ID: 18952719
[TBL] [Abstract][Full Text] [Related]
28. Vagus nerve stimulation in experimental heart failure.
Sabbah HN; Ilsar I; Zaretsky A; Rastogi S; Wang M; Gupta RC
Heart Fail Rev; 2011 Mar; 16(2):171-8. PubMed ID: 21128115
[TBL] [Abstract][Full Text] [Related]
29. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN
J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662
[TBL] [Abstract][Full Text] [Related]
30. Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.
DeMazumder D; Kass DA; O'Rourke B; Tomaselli GF
Circ Res; 2015 May; 116(10):1691-9. PubMed ID: 25733594
[TBL] [Abstract][Full Text] [Related]
31. Continuous low-level vagus nerve stimulation reduces stellate ganglion nerve activity and paroxysmal atrial tachyarrhythmias in ambulatory canines.
Shen MJ; Shinohara T; Park HW; Frick K; Ice DS; Choi EK; Han S; Maruyama M; Sharma R; Shen C; Fishbein MC; Chen LS; Lopshire JC; Zipes DP; Lin SF; Chen PS
Circulation; 2011 May; 123(20):2204-12. PubMed ID: 21555706
[TBL] [Abstract][Full Text] [Related]
32. Chronic vagal nerve stimulation has no effect on tachycardia-induced heart failure progression or excitation-contraction coupling.
Radcliffe EJ; Pearman CM; Watkins A; Lawless M; Kirkwood GJ; Saxton SN; Eisner DA; Trafford AW
Physiol Rep; 2020 Jan; 8(2):e14321. PubMed ID: 31961064
[TBL] [Abstract][Full Text] [Related]
33. Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study.
DiCarlo LA; Libbus I; Kumar HU; Mittal S; Premchand RK; Amurthur B; KenKnight BH; Ardell JL; Anand IS
ESC Heart Fail; 2018 Feb; 5(1):95-100. PubMed ID: 29283224
[TBL] [Abstract][Full Text] [Related]
34. Unilateral vagus nerve stimulation improves ventricular autonomic nerve distribution and functional imbalance in a canine heart failure model.
Sun J; Lu Y; Huang Y; Wugeti N
Int J Clin Exp Med; 2015; 8(6):9334-40. PubMed ID: 26309593
[TBL] [Abstract][Full Text] [Related]
35. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure.
Morita H; Suzuki G; Haddad W; Mika Y; Tanhehco EJ; Sharov VG; Goldstein S; Ben-Haim S; Sabbah HN
J Card Fail; 2003 Feb; 9(1):69-75. PubMed ID: 12612875
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of ganglionated plexus attenuates cardiac neural remodeling and heart failure progression in a canine model of acute heart failure post-myocardial infarction.
Luo D; Hu H; Qin Z; Liu S; Yu X; Ma R; He W; Xie J; Lu Z; He B; Jiang H
Auton Neurosci; 2017 Dec; 208():73-79. PubMed ID: 28941985
[TBL] [Abstract][Full Text] [Related]
37. Vagus nerve stimulation mitigates intrinsic cardiac neuronal remodeling and cardiac hypertrophy induced by chronic pressure overload in guinea pig.
Beaumont E; Wright GL; Southerland EM; Li Y; Chui R; KenKnight BH; Armour JA; Ardell JL
Am J Physiol Heart Circ Physiol; 2016 May; 310(10):H1349-59. PubMed ID: 26993230
[TBL] [Abstract][Full Text] [Related]
38. Quantitative evaluation of heartbeat interval time series using Poincaré analysis reveals distinct patterns of heart rate dynamics during cycles of vagus nerve stimulation in patients with heart failure.
Libbus I; Nearing BD; Amurthur B; KenKnight BH; Verrier RL
J Electrocardiol; 2017; 50(6):898-903. PubMed ID: 28625397
[TBL] [Abstract][Full Text] [Related]
39. Chronic cyclic vagus nerve stimulation has beneficial electrophysiological effects on healthy hearts in the absence of autonomic imbalance.
Lee SW; Li Q; Libbus I; Xie X; KenKnight BH; Garry MG; Tolkacheva EG
Physiol Rep; 2016 May; 4(9):. PubMed ID: 27173672
[TBL] [Abstract][Full Text] [Related]
40. Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure.
Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2002 May; 16(3):209-14. PubMed ID: 12374898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
